Home
Membership
Get Involved
Conferences
Education
Public Affairs
Publications
Grants
Awards
About Us
Vacancies


Molecular mechanisms of glucolipotoxicity in diabetes

25—26 March 2008

University College Dublin, Ireland



Organizers:
Philip Newsholme (University College Dublin, Ireland)
Mark Holness (Barts and the London School of Medicine and Dentistry, UK)
Tony Corfield (University of Bristol, UK)

Timetable

Tuesday 25 March 2008Wednesday 26 March 2008
10:30 - 13:00
Insulin secretion

14:30 - 17:00
Beta cell apoptosis

09:00 - 10:45
Signalling in glucolipotoxicity

11:20 - 13:35
Mitochondrial dysfunction and aspects of dysregulated metabolism 1

15:00 - 17:30
Mitochondrial dysfunction and aspects of dysregulated metabolism 2


Insulin secretion

Chair:
Philip Newsholme (University College Dublin, Ireland)
Tuesday 25 March 2008
09:00 - 10:30 Registration

10:30 - 11:15
b-cell lipases and insulin secretion
Hindrik Mulder (University of Lund, Sweden)
11:15 - 12:00
Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance
Mary Sugden (Barts and the London School of Medicine and Dentistry, UK)
12:00 - 12:45
Glucolipotoxicity of the pancreatic b-cell: myth or reality?
Vincent Poitout (University of Montreal, Canada)
12:45 - 13:00
Arachidonic acid induces changes in gene expression and insulin secretion in the BRIN BD11 clonal rat pancreatic beta-cell line
Selected oral communication - Deirdre Keane (University College Dublin, Ireland)
13:00 - 14:30 Lunch and poster viewing

Beta cell apoptosis

Chair:
Mark Holness (Barts and the London School of Medicine and Dentistry, UK)
Tuesday 25 March 2008
14:30 - 15:15
Metabolic stress and islet inflammation: physiology, pathology and therapy
Marc Donath (University Hospital Zurich, Switzerland)
15:15 - 16:00
The cytoprotective actions of mono-unsaturated fatty acids in the pancreatic b-cell
Noel Morgan (Peninsula Medical School, UK)
16:00 - 16:45
The role of endoplasmic reticulum stress in lipotoxicity
Miriam Cnop (Free University of Brussels, Belgium)
16:45 - 17:00
Differential regulation of the ER stress response in pancreatic beta-cells exposed to long chain saturated and mono-unsaturated fatty acids
Selected oral communication - Eleftheria Diakogiannaki (Peninsula Medical School, UK)
17:00 - 18:30 Drinks reception and Poster Session 1 (odd numbers)

Signalling in glucolipotoxicity

Chair:
Derek Brazil (University College Dublin, Ireland)
Wednesday 26 March 2008
09:00 - 09:45
PKCepsilon is a potential target for the treatment of b-cell secretory dysfunction
Trevor Biden (Garvan Institute of Medical Research, Australia)
09:45 - 10:30
The NOX family of ROS generating NADPH oxidases: from physiology to toxicity
Karl-Heinz Krause (University of Geneva, Switzerland)
10:30 - 10:45
High glucose activates Hypoxia Inducible Factor 1 alpha (HIF1alpha) and HIF2alpha in cultured rat beta-cells
Selected oral communication - Mohammed Bensellam (University of Louvain, Belgium)
10:45 - 11:20 Coffee/tea break

Mitochondrial dysfunction and aspects of dysregulated metabolism 1

Chair:
Neville McClenaghan (University of Ulster, Ireland)
Wednesday 26 March 2008
11:20 - 12:05
Beta-cell sensitivity to mitochondrial injuries
Pierre Maechler (University of Geneva, Switzerland)
12:05 - 12:50
Adipose tissue expandability and lipotoxicity
Antonio Vidal-Puig (University of Cambridge, UK)
12:50 - 13:35
Regulation and consequences of differential gene expression in diabetic kidney disease
Catherine Godson (University College Dublin, Ireland)
13:35 - 15:00 Lunch and Poster Session 2 (even numbers)

Mitochondrial dysfunction and aspects of dysregulated metabolism 2

Chair:
Tony Corfield (University of Bristol, UK)
Wednesday 26 March 2008
15:00 - 15:45
Dynamic interplay between GlcNAcylation & phosphorylation: roles in nutrient toxicity & signaling
Gerry Hart (John Hopkins University School of Medicine, USA)
15:45 - 16:30
Molecular mechanisms of proteinuria in diabetes
Luigi Gnudi (Kings College London, UK)
16:30 - 17:15
Pharmacological approaches to regulation of insulin secretion and glucolipotoxicity with emphasis on GPR40
Dave Smith (AstraZeneca, UK)
17:15 - 17:30
Lack of TXNIP Protects Beta Cells Against Glucotoxicity
Selected oral communication - Anath Shalev (University of Wisconsin-Madison, USA)
17:30 - 17:45 Closing remarks